AGLE
Aeglea Biotherapeutics, Inc.
Interim CEO Anthony G. Quinn bought $41K of Aeglea Biotherapeutics, Inc.
Bought$41,078
$4.96Price
8,288Shares
+31%Stake
What AGLE did for a copier
Prices for AGLE after this filing aren't in yet.
Anthony G. Quinn's record
9 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Dec 6. Filed Fri, Dec 8, 2:06 PM ET, during the session. Not investment advice.